Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Peter Hartung

Showing results (81-90 of 601) with videos related to

Pageof 61
Sort By:
Neurology Research International|April 4, 2019
Prominent T-Cell Responses against the Acetylcholine Receptor <i>ε</i> Subunit in Myasthenia GravisOliver Neuhaus, Karl-Heinz Wiesmüller, Hans-Peter Hartung, et al.
Current Opinion in Neurology|May 15, 2007
Treatment and treatment trials in multiple sclerosisBernd C Kieseier, Heinz Wiendl, Bernhard Hemmer, et al.
Qatar Medical Journal|November 29, 2023
Immunomodulatory potential of anti-IFN-beta antibodies on monocyte-derived macrophagesAjith Sominanda, Til Menge, Hans Peter Hartung, et al.
Current Opinion in Neurology|May 14, 2005
Chronic inflammatory demyelinating polyneuropathy--update on pathogenesis, diagnostic criteria and therapyHubertus Köller, Michael Schroeter, Bernd C Kieseier, et al.
The Lancet. Neurology|May 26, 2004
Are statins a treatment option for multiple sclerosis?Oliver Neuhaus, Olaf Stüve, Scott S Zamvil, et al.
Nature Clinical Practice. Neurology|April 6, 2007
From bench to bedside--experimental rationale for immune-specific therapies in the inflamed peripheral nerveGerd Meyer zu Hörste, Hans-Peter Hartung, Bernd C Kieseier
Progress in Neurobiology|June 19, 2010
Animal models of multiple sclerosis--potentials and limitationsEilhard Mix, Hans Meyer-Rienecker, Hans-Peter Hartung, et al.
BMC Neuroscience|August 8, 2009
Niche-dependent development of functional neuronal networks from embryonic stem cell-derived neural populationsSebastian Illes, Stephan Theiss, Hans-Peter Hartung, et al.
Muscle & Nerve|April 21, 2020
Management challenges for chronic dysimmune neuropathies during the COVID-19 pandemicYusuf A Rajabally, H Stephan Goedee, Shahram Attarian, et al.
Current Opinion in Neurology|May 14, 2021
Stopping disease-modifying therapy in relapsing and progressive multiple sclerosisHans-Peter Hartung, Sven G Meuth, Deborah M Miller, et al.
Pageof 61

Showing results (81-90 of 601) with videos related to

Sort By:
Pageof 61
Neurology Research International|April 4, 2019
Prominent T-Cell Responses against the Acetylcholine Receptor <i>ε</i> Subunit in Myasthenia GravisOliver Neuhaus, Karl-Heinz Wiesmüller, Hans-Peter Hartung, et al.
Current Opinion in Neurology|May 15, 2007
Treatment and treatment trials in multiple sclerosisBernd C Kieseier, Heinz Wiendl, Bernhard Hemmer, et al.
Qatar Medical Journal|November 29, 2023
Immunomodulatory potential of anti-IFN-beta antibodies on monocyte-derived macrophagesAjith Sominanda, Til Menge, Hans Peter Hartung, et al.
Current Opinion in Neurology|May 14, 2005
Chronic inflammatory demyelinating polyneuropathy--update on pathogenesis, diagnostic criteria and therapyHubertus Köller, Michael Schroeter, Bernd C Kieseier, et al.
The Lancet. Neurology|May 26, 2004
Are statins a treatment option for multiple sclerosis?Oliver Neuhaus, Olaf Stüve, Scott S Zamvil, et al.
Nature Clinical Practice. Neurology|April 6, 2007
From bench to bedside--experimental rationale for immune-specific therapies in the inflamed peripheral nerveGerd Meyer zu Hörste, Hans-Peter Hartung, Bernd C Kieseier
Progress in Neurobiology|June 19, 2010
Animal models of multiple sclerosis--potentials and limitationsEilhard Mix, Hans Meyer-Rienecker, Hans-Peter Hartung, et al.
BMC Neuroscience|August 8, 2009
Niche-dependent development of functional neuronal networks from embryonic stem cell-derived neural populationsSebastian Illes, Stephan Theiss, Hans-Peter Hartung, et al.
Muscle & Nerve|April 21, 2020
Management challenges for chronic dysimmune neuropathies during the COVID-19 pandemicYusuf A Rajabally, H Stephan Goedee, Shahram Attarian, et al.
Current Opinion in Neurology|May 14, 2021
Stopping disease-modifying therapy in relapsing and progressive multiple sclerosisHans-Peter Hartung, Sven G Meuth, Deborah M Miller, et al.
Pageof 61